Nika Pharmaceuticals, Inc (NIKA) stock
NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.00 (0.00%)
Close on Oct 16, 2026Market cap $431.19MP/E –Yield –
Nika Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nika Pharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $0. For fiscal 2024 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
See a number that looks wrong?